Trang chủ

Tài liệu nghiên cứu Y học

Search Journal

Search Article

Search by Auth

Category

From

To

European Journal of Cancer

1. Overestimated treatment effects in randomised phase II trials: What's up doctor?

Tác giả

Stefan Michiels, James Wason.

1. Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

Tác giả

Amal Kamal Abdel-Aziz, Mona Kamal Saadeldin, Paolo D'Amico, Stefania Orecchioni, Saverio Minucci.

1. Pemetrexed exposure predicts toxicity in advanced non–small-cell lung cancer: A prospective cohort study

Tác giả

S. Visser, S.L.W. Koolen, P. de Bruijn, H.N.A. Belderbos, J.G.J.V. Aerts.

1. Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies

Tác giả

Pauline Corbaux, Mévidette El-Madani, Michel Tod, Julien Péron, Benoit You.

1. Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors

Tác giả

Lih-Chyun Chang, Chor-Kuan Lim, Lih-Yu Chang, Kuan-Yu Chen, Chong-Jen Yu.

1. New evidence and hope for young patients with breast cancer

Tác giả

Michael Gnant.

1. Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial

Tác giả

F.E. Marti Marti, G.C. Jayson, P. Manoharan, J. O'Connor, M.P. Saunders.

1. Reproductive factors associated with breast cancer risk in Li–Fraumeni syndrome

Tác giả

Payal P. Khincha, Ana F. Best, Joseph F. Fraumeni, Jennifer T. Loud, Maria Isabel Achatz.

1. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program–sponsored phase I trials

Tác giả

Shun Kishimoto, Nobu Oshima, Matthew Rinker, Murali C. Krishna, Naoko Takebe.

1. Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services

Tác giả

Cathryn A. Moss, Elena Cojocaru, Janet Hanwell, Simon Ward, Terri P. McVeigh.

1. Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma

Tác giả

Daniel R. McGowan, Michael Skwarski, Kevin M. Bradley, Leticia Campo, Geoff S. Higgins.

1. Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system

Tác giả

Lauren E. Haydu, John F. Thompson, Richard A. Scolyer, Jeffrey E. Gershenwald.

1. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials

Tác giả

S. Cascinu, D. Poli, A. Zaniboni, S. Lonardi, V. Torri.

1. Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

Tác giả

M. Ekholm, P.O. Bendahl, M. Fernö, B. Nordenskjöld, L. Rydén.

1. A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 ‘CREATE’ trial

Tác giả

Julien Péron, Sandrine Marreaud, Dominiek Staelens, Tiana Raveloarivahy, Patrick Schöffski.

1. Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial

Tác giả

Lorenzo Livi, Vieri Scotti, Isacco Desideri, Calogero Saieva, Icro Meattini.

1. Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers

Tác giả

Bradley Downs, Simon Sherman, Jian Cui, Yeong C. Kim, San Ming Wang.

1. Induction chemotherapy in borderline (non-)resectable pancreatic cancer: a unique window of opportunity for understanding pancreatic cancer

Tác giả

Jean-Luc Van Laethem.

2. Valuing preferences for treating screen detected ductal carcinoma in situ

Tác giả

Hannah L. Bromley, G. Bruce Mann, Dennis Petrie, Carolyn Nickson, Tracy E. Roberts.

2. UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2–positive subgroup

Tác giả

Véronique D'Hondt, Jean-Luc Canon, Lise Roca, Christelle Levy, Florence Dalenc.

2. EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases

Tác giả

Tao Jiang, Yongchang Zhang, Xuefei Li, Chao Zhao, Caicun Zhou.

2. Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2–positive breast cancer

Tác giả

Xavier Pivot, Mark Pegram, Javier Cortes, Diana Lüftner, Chul Kim.

2. Challenging the recalcitrant disease—developing molecularly driven treatments for small cell lung cancer

Tác giả

Daisy W.S. Mak, Su Li, Anna Minchom.

2. The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study

Tác giả

Serena Di Cosimo, Tiziana Triulzi, Sara Pizzamiglio, Loris De Cecco, Elda Tagliabue.

2. Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?

Tác giả

Carmen Criscitiello, Giuseppe Curigliano.

2. Clinical outcomes of non–small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study

Tác giả

Sébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, Didier Debieuvre, David Planchard.

2. Screening for brain metastases in patients with stage III non–small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study

Tác giả

Janna Schoenmaekers, Paul Hofman, Gerben Bootsma, Marcel Westenend, Lizza E.L. Hendriks.

2. Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial

Tác giả

Michael J. Morris, Yohann Loriot, Christopher J. Sweeney, Karim Fizazi, Celestia S. Higano.

2. Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study

Tác giả

Yuki Katsuya, Hidehito Horinouchi, Takashi Seto, Shigeki Umemura, Yuichiro Ohe.

2. Statins – No more cream for cancer

Tác giả

S. Gillessen, L.G. Horvath.

2. Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

Tác giả

A. Adenis, J. Bennouna, P.L. Etienne, E. Bogart, M.C. Le Deley.

2. Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials

Tác giả

Shrinivas Rathod, Branislav Jeremic, Arbind Dubey, Meredith Giuliani, Rashmi Koul.

2. First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity

Tác giả

Sophie Postel-Vinay, Karin Herbschleb, Christophe Massard, Victoria Woodcock, Mark Middleton.

2. Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer

Tác giả

Benjamin P. Levy, Giuseppe Giaccone, Benjamin Besse, Enriqueta Felip, Luis Paz-Ares.

2. Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

Tác giả

J. von Pawel, R. Bordoni, M. Satouchi, L. Fehrenbacher, K. Park.

2. European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer

Tác giả

Emiel Rutgers, Judith Balmana, Marc Beishon, Karen Benn, Lynda Wyld.

3. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion

Tác giả

Lizza E.L. Hendriks, Christophe Dooms, Thierry Berghmans, Silvia Novello, Anne-Marie C. Dingemans.

3. Association between EGFR mutation and ageing, history of pneumonia and gastroesophageal reflux disease among patients with advanced lung cancer

Tác giả

Won-Il Choi, Jihyeon Jeong, Choong Won Lee.

3. Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials

Tác giả

Michael Davidson, Anna Dorothea Wagner, Kyriakos Kouvelakis, Henry Nanji, David Cunningham.

3. Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial

Tác giả

Mark Robson, Kathryn J. Ruddy, Seock-Ah IM, Elżbieta Senkus, Pierfranco Conte.

3. Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study

Tác giả

Claire Gallois, Pascal Artru, Astrid Lièvre, Edouard Auclin, Julien Taieb.

3. Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

Tác giả

Tomohiro Ochi, Giampaolo Bianchini, Michiko Ando, Fumi Nozaki, Naoki Hayashi.

3. Long-term excess risk of breast cancer after a single breast density measurement

Tác giả

Matejka Rebolj, Oleg Blyuss, Kee Seng Chia, Stephen W. Duffy.

3. Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

Tác giả

Martin Reck, Michael Schenker, Ki Hyeong Lee, Mariano Provencio, Julie Brahmer.

3. FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial

Tác giả

David Malka, Eric François, Frédérique Penault-Llorca, Florence Castan, Julien Taïeb.

3. Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)

Tác giả

Amelia McCartney, Chiara Biagioni, Gaia Schiavon, Mattias Bergqvist, Luca Malorni.

3. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice

Tác giả

C. Newton, K. Murali, A. Ahmad, H. Hockings, M. Lockley.

3. Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer

Tác giả

Guillem Argilés, Thierry André, Antoine Hollebecque, Aitana Calvo, Josep Tabernero.

3. Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer

Tác giả

Taisuke Yagi, Yoshifumi Baba, Kazuo Okadome, Yuki Kiyozumi, Hideo Baba.

3. Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial

Tác giả

Gianluca Masi, Caterina Vivaldi, Lorenzo Fornaro, Sara Lonardi, Alfredo Falcone.

3. A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes

Tác giả

Kan Yonemori, Akihiko Shimomura, Hiroyuki Yasojima, Norikazu Masuda, Yasuhiro Fujiwara.

3. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study

Tác giả

Jean-Pierre Gérard, Nicolas Barbet, Jocelyn Gal, Catherine Dejean, Eric François.

3. Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)

Tác giả

S. Watson, C. de la Fouchardière, S. Kim, R. Cohen, C. Louvet.

3. Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations

Tác giả

Christian F. Singer, Judith Balmaña, Nicole Bürki, Suzette Delaloge, D. Gareth Evans.

4. Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer

Tác giả

Francesco Grossi, Carlo Genova, Lucio Crinò, Angelo Delmonte, Enrico Cortesi.

4. EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease

Tác giả

Antonin Levy, Lizza E.L. Hendriks, Thierry Berghmans, Corinne Faivre-Finn, Anne-Marie C. Dingemans.

4. Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC)

Tác giả

Eleonor Rivin del Campo, Oscar Matzinger, Karin Haustermans, Didier Peiffert, Philippe Maingon.

4. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion

Tác giả

Ana Lluch, Ana M. González-Angulo, David Casadevall, Agda K. Eterovic, Joan Albanell.

4. A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registries

Tác giả

Adriana Della Valle, Benedito Mauro Rossi, Edenir Inêz Palmero, Marina Antelo, Mev Dominguez-Valentin.

4. Assessment of the efficacy of successive endocrine therapies in hormone receptor–positive and HER2-negative metastatic breast cancer: a real-life multicentre national study

Tác giả

Olivia Le Saux, Audrey Lardy-Cleaud, Sophie Frank, Marc Debled, Thomas Bachelot.

4. Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials

Tác giả

M. Martín, S. Loibl, T. Hyslop, J. De la Haba-Rodríguez, M.N. Dickler.

4. Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors

Tác giả

Lizza E.L. Hendriks, Gerben Bootsma, Jean Mourlanette, Clemence Henon, Benjamin Besse .

4. A phase II study of carboplatin AUC-10 guided by positron emission tomography–defined metabolic response in metastatic seminoma

Tác giả

Jonathan Shamash, Rizwan Syed, Shah-Jalal Sarker, Naveed Sarwar, Gordon J. Rustin.

4. Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study

Tác giả

Aurelia Noske, Volker Möbus, Karsten Weber, Sabine Schmatloch, Carsten Denkert.

4. Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study

Tác giả

Janneke C. Ham, Chantal M. Driessen, Mathijs P. Hendriks, Edward Fiets, Carla M. van Herpen.

4. Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial

Tác giả

Peng Yuan, Xichun Hu, Tao Sun, Wei Li, Binghe Xu.

4. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial

Tác giả

Keisuke Kosumi, Tsuyoshi Hamada, Sui Zhang, Li Liu, Shuji Ogino.

4. Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma

Tác giả

Xiao-Yun Li, Qiu-Yan Chen, Xue-Song Sun, Sai-Lan Liu, Hai-Qiang Mai.

4. Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

Tác giả

Filippo Montemurro, Paul Ellis, Antonio Anton, Rachel Wuerstlein, Carlos H. Barrios.

4. A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Tác giả

Y.-J. Bang, Y.-K. Kang, M. Ng, H.C. Chung, J.A. Ajani.

4. Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program

Tác giả

Andrea Buron, Marta Román, Josep M. Augé, Francesc Macià, Xavier Castells.

4. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA

Tác giả

Zhong Ye, Chun Wang, Shaogui Wan, Zhaomei Mu, Hushan Yang.

5. DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial

Tác giả

Raghav Sundar, Alvin Ng, Hermioni Zouridis, Nisha Padmanabhan, Patrick Tan.

5. The significance of tumour deposits in rectal cancer after neoadjuvant therapy: a systematic review and meta-analysis

Tác giả

A.C. Lord, C. Graham Martínez, N. D'Souza, P.H. Pucher, I.D. Nagtegaal.

5. Clinical features of neuroendocrine prostate cancer

Tác giả

Vincenza Conteduca, Clara Oromendia, Kenneth W. Eng, Rohan Bareja, Himisha Beltran.

5. Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancer

Tác giả

Caroline Truntzer, Nicolas Isambert, Laurent Arnould, Sylvain Ladoire, Francois Ghiringhelli.

5. SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

Tác giả

Y. Munemoto, M. Nakamura, M. Takahashi, M. Kotaka, N. Nagata.

5. Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

Tác giả

Jens Huober, Eileen Holmes, José Baselga, Evandro de Azambuja, Serena Di Cosimo.

5. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

Tác giả

C.R. Lindsay, F.H. Blackhall, A. Carmel, F. Fernandez-Gutierrez, S. Michiels.

5. The gap in postoperative outcome between older and younger patients with stage I-III colorectal cancer has been bridged; results from the Netherlands cancer registry

Tác giả

Nelleke P.M. Brouwer, Thea C. Heil, Marcel G.M. Olde Rikkert, Valery E.P.P. Lemmens, Felice N. van Erning.

5. Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting

Tác giả

Roberta Depenni, Maria Cossu Rocca, Daris Ferrari, Giuseppe Azzarello, Paolo Bossi.

5. Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors

Tác giả

A.Y. Shah, R.R. Kotecha, E.A. Lemke, A. Chandramohan, N.M. Tannir.

5. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task

Tác giả

Titus J. Brinker, Achim Hekler, Alexander H. Enk, Joachim Klode, Philipp Schrüfer.

5. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma

Tác giả

Manfred P. Lutz, John R. Zalcberg, Michel Ducreux, Antoine Adenis, Florian Otto.

5. Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations

Tác giả

Cindy Neuzillet, Andrea Casadei Gardini, Bertrand Brieau, Caterina Vivaldi, David Propper.

5. Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

Tác giả

W. van Boxtel, L.D. Locati, A.C.H. van Engen-van Grunsven, C. Bergamini, C.M.L. van Herpen.

5. Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer

Tác giả

Edwin A. Basak, Stijn L.W. Koolen, Daan P. Hurkmans, Marco W.J. Schreurs, Ron H.J. Mathijssen.

5. NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors

Tác giả

Andrea Wang-Gillam, Richard A. Hubner, Jens T. Siveke, Daniel D. Von Hoff, Li-Tzong Chen.

5. Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial

Tác giả

Mitsukuni Suenaga, Sebastian Stintzing, Shu Cao, Wu Zhang, Heinz-Josef Lenz.

5. Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised pha

Tác giả

Andreas Schneeweiss, Volker Möbus, Hans Tesch, Claus Hanusch, Sibylle Loibl.

6. Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study

Tác giả

Thomas Walter, Come Lepage, Romain Coriat, Emilie Barbier, Thierry de Baère.

6. Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme

Tác giả

Michael Davidson, Lauren I. Aronson, Julie Howard-Reeves, Hanna Bryant, Irene Y. Chong.

6. Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer

Tác giả

Bodine P.S. Belderbos, Anieta M. Sieuwerts, Esther Oomen-de Hoop, Bianca Mostert, Martijn P. Lolkema.

6. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation

Tác giả

Ping Yuan, Sha Huang, Fei-Chao Bao, Jin-Lin Cao, Jian Hu.

6. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial

Tác giả

Qi Yang, Su-Mei Cao, Ling Guo, Yi-Jun Hua, Ming-Yuan Chen.

6. Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

Tác giả

E. Gezelius, P.O. Bendahl, K. Gonçalves de Oliveira, L. Ek, M. Belting.

6. Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

Tác giả

Zong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, Kuan-Yu Chen, Chong-Jen Yu.

6. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma

Tác giả

Jessica Howell, Stephen R. Atkinson, David J. Pinato, Susanne Knapp, Rohini Sharma.

6. High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort

Tác giả

Lars Bastholt, Inge Marie Svane, Jon Kroll Bjerregaard, Jørn Herrstedt, Henrik Schmidt.

6. An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma

Tác giả

Martin G. Cook, Daniela Massi, Anna Szumera-Ciećkiewicz, Joost Van den Oord, Alexander C.J. van Akkooi.

6. Cardiorespiratory fitness and site-specific risk of cancer in men: A systematic review and meta-analysis

Tác giả

D.P. Pozuelo-Carrascosa, C. Alvarez-Bueno, I. Cavero-Redondo, S. Morais, V. Martínez-Vizcaíno.

6. Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer

Tác giả

Chan Kim, Hong Jae Chon, Joo Hoon Kim, Minkyu Jung, Sun Young Rha.

6. Therapeutic drug monitoring as a tool to optimize 5-FU–based chemotherapy in gastrointestinal cancer patients older than 75 years

Tác giả

Pauline Macaire, Katarzyna Morawska, Julie Vincent, Valérie Quipourt, Antonin Schmitt.

6. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases

Tác giả

Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, Dirk Daubner, Friedegund Meier.

6. Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study

Tác giả

W. Victoria Lai, Louisiane Lebas, Tristan A. Barnes, Julie Milia, Bob T. Li.

6. Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

Tác giả

Marie Auvray, Edouard Auclin, Philippe Barthelemy, Petri Bono, Laurence Albiges.

6. Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials

Tác giả

Ian Chau, Charles S. Fuchs, Atsushi Ohtsu, Afsaneh Barzi, Salah-Eddin Al-Batran.

6. Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer

Tác giả

Arsela Prelaj, Rebecca Tay, Roberto Ferrara, Nathalie Chaput, Raffaele Califano.

7. Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials

Tác giả

Ulrich Ronellenfitsch, Katrin Jensen, Svenja Seide, Meinhard Kieser, Sylvie Lorenzen.

7. Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

Tác giả

K. Klinghammer, T. Gauler, A. Dietz, V. Grünwald, U. Keilholz.

7. Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Tác giả

Khalil Saleh, Amaury Daste, Nicolas Martin, Elvire Pons-Tostivint, Caroline Even.

7. The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy

Tác giả

Siow Ming Lee, Sunil Upadhyay, Conrad Lewanski, Stephen Falk, Allan Hackshaw.

7. Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

Tác giả

Alexander M.M. Eggermont, Vanna Chiarion-Sileni, Jean-Jacques Grob, Reinhard Dummer, Alessandro Testori.

7. The impact of severe mental illness on lung cancer mortality of patients with lung cancer in Finland in 1990–2013: a register-based cohort study

Tác giả

Martti Arffman, Kristiina Manderbacka, Jaana Suvisaari, Jussi Koivunen, Eero Pukkala.

7. The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy

Tác giả

Massimiliano Salati, Francesco Caputo, David Cunningham, Luigi Marcheselli, Chiara Braconi.

7. High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR–directed monoclonal antibody (EXPAND trial) showing no prognostic impact

Tác giả

Radka Obermannova, Dalibor Valik, Dirk Hasenclever, Lenka Zdrazilova-Dubska, Florian Lordick.

7. Pathologist-level classification of histopathological melanoma images with deep neural networks

Tác giả

Achim Hekler, Jochen Sven Utikal, Alexander H. Enk, Carola Berking, Titus Josef Brinker.

7. Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

Tác giả

Celeste Lebbe, Claus Garbe, Alexander J. Stratigos, Catherine Harwood, Cecile Pages.

7. Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma

Tác giả

Alec J. Kacew, Ethan J. Harris, Jochen H. Lorch, Robert I. Haddad, Glenn J. Hanna.

7. Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy

Tác giả

Szu-Yuan Wu, Su-Chen Fang, Hung-Jen Shih, Yu-Chin Wen, Yu-Hsuan Joni Shao.

7. Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3

Tác giả

Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, Shu Cao, Heinz-Josef Lenz.

7. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children

Tác giả

Andrew D.J. Pearson, Nicole Scobie, Koenraad Norga, Franca Ligas, Gilles Vassal.

7. A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)

Tác giả

Zhen Wang, Cheng Huang, Jin-Ji Yang, Yong Song, Yi-Long Wu.

7. The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial

Tác giả

Georg A. Bjarnason, Jennifer J. Knox, Christian K. Kollmannsberger, Denis Soulieres, Naveen S. Basappa.

7. Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase

Tác giả

Sarit Schwartz, Chris Szeto, Yuan Tian, Fabiola Cecchi, Filippo Pietrantonio.

7. Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin

Tác giả

Richard A. Hubner, Antonio Cubillo, Jean-Frédéric Blanc, Davide Melisi, Jens T. Siveke.

8. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications

Tác giả

B. Soldevilla, C. Carretero-Puche, G. Gomez-Lopez, F. Al-Shahrour, R. Garcia-Carbonero.

8. Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10–14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study

Tác giả

Anna Maria Testi, Andishe Attarbaschi, Maria Grazia Valsecchi, Anja Möricke, Martin Schrappe.

8. Measured and genetically predicted plasma YKL-40 levels and melanoma mortality

Tác giả

Hafsa Ismail, Jens Helby, Lisbet R. Hölmich, Annette H. Chakera, Stig E. Bojesen.

8. Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?

Tác giả

E.E.C. de Jong, K.J.C. Sanders, T.M. Deist, W. van Elmpt, P. Lambin.

8. Deep neural networks are superior to dermatologists in melanoma image classification

Tác giả

Titus J. Brinker, Achim Hekler, Alexander H. Enk, Carola Berking, Jochen S. Utikal.

8. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening

Tác giả

U. Pastorino, N. Sverzellati, S. Sestini, M. Silva, A. Marchianò.

8. Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy

Tác giả

Chee Khoon Lee, Rebecca Asher, Michael Friedlander, Val Gebski, Eric Pujade-Lauraine.

8. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

Tác giả

H.J. Boyle, S. Alibhai, L. Decoster, E. Efstathiou, J.-P. Droz.

8. Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

Tác giả

S. Mannisto, P. Vähämurto, M. Pollari, M.R. Clausen, S. Leppä.

8. Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience

Tác giả

Elke Pfaff, Ahmed El Damaty, Gnana Prakash Balasubramanian, Mirjam Blattner-Johnson, Olaf Witt.

8. Immune checkpoint inhibitor–associated hypophysitis—World Health Organisation VigiBase report analysis

Tác giả

Elisa Guerrero, Douglas B. Johnson, Anne Bachelot, Bénédicte Lebrun-Vignes, Joe-Elie Salem.

8. Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications

Tác giả

Maria I. Van Rompay, Keith R. Solomon, J. Curtis Nickel, Gayatri Ranganathan, John B. McKinlay.

8. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery

Tác giả

Martina Delle Marchette, Lorenzo Ceppi, Anita Andreano, Cristina Maria Bonazzi, Robert Fruscio.

8. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors

Tác giả

Andrea Ferrari, Ines B. Brecht, Gemma Gatta, Dominik T. Schneider, Annalisa Trama.

8. Treatment sequencing in metastatic colorectal cancer

Tác giả

D.P. Modest, S. Pant, A. Sartore-Bianchi.

8. Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer

Tác giả

Mathieu Rouanne, Reem Betari, Camélia Radulescu, Aïcha Goubar, Thierry Lebret.

8. SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

Tác giả

Margitta Retz, Jens Bedke, Martin Bögemann, Marc-Oliver Grimm, Jürgen E. Gschwend.

8. Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis

Tác giả

Alexander Baraniskin, Barbara Buchberger, Christian Pox, Ulli Graeven, Volker Heinemann.

9. Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study

Tác giả

Michel Ducreux, Lone Nørgård Petersen, Leopold Öhler, Francesca Bergamo, Alfredo Falcone.

9. Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?

Tác giả

J.M. Michot, J. Lazarovici, A. Tieu, S. Champiat, O. Lambotte.

9. Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

Tác giả

Dirk Schadendorf, Paolo A. Ascierto, John Haanen, Enrique Espinosa, Paul Nathan.

9. Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker

Tác giả

Heejung Chae, Deokhoon Kim, Changhoon Yoo, Kyu-pyo Kim, Baek-Yeol Ryoo.

9. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma

Tác giả

Theodora Kanaki, Andreas Stang, Ralf Gutzmer, Lisa Zimmer, Elisabeth Livingstone.

9. A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

Tác giả

Fotios Loupakis, Rossana Intini, Chiara Cremolini, Armando Orlandi, Massimo Di Maio.

9. Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma

Tác giả

Abdul K. Siraj, Poyil Pratheeshkumar, Sandeep Kumar Parvathareddy, Rong Bu, Khawla S. Al-Kuraya.

9. Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer

Tác giả

Vincenza Conteduca, Elena Castro, Daniel Wetterskog, Emanuela Scarpi, Ugo De Giorgi.

9. Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation

Tác giả

Guillaume Manson, Jean-Baptiste Mear, Charles Herbaux, Jean-Marc Schiano, Roch Houot.

9. Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial setting

Tác giả

Marion Smits, Martin Bendszus, Sandra Collette, Linda A. Postma, Sabine Heiland.

9. Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?

Tác giả

Arnaud Bayle, Benjamin Besse, Maxime Annereau, Julia Bonastre.

9. Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort

Tác giả

Pauline Tétu, Clara Allayous, Bastien Oriano, Stéphane Dalle, Céleste Lebbe.

9. Perinatal complications in female survivors of cancer: a systematic review and meta-analysis

Tác giả

Anne-Lotte L.F. van der Kooi, Tom W. Kelsey, Marry M. van den Heuvel-Eibrink, Joop S.E. Laven, Richard A. Anderson.

9. Avoidable cancers in the Nordic countries—the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer

Tác giả

Therese M-L. Andersson, Gerda Engholm, Anne-Sofie Q. Lund, Sofia Lourenço, Hans Storm.

9. Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial

Tác giả

Chiara Cremolini, Federica Marmorino, Francesca Bergamo, Giuseppe Aprile, Alfredo Falcone.

9. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma

Tác giả

Claire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, Julien Berthiller, Françoise Borson-Chazot.

9. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre

Tác giả

F. Ruatta, L. Derosa, B. Escudier, E. Colomba, L. Albiges.

9. Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score–matched analysis

Tác giả

Mamiko Imanishi, Yoshiyuki Yamamoto, Yukako Hamano, Takeshi Yamada, ... Ichinosuke Hyodo.

10. Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial

Tác giả

Atul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, V. Sreenivas, Vinod Raina.

10. The transformation of radiation oncology using real-time magnetic resonance guidance: A review

Tác giả

William A. Hall, Eric S. Paulson, Uulke A. van der Heide, Clifton D. Fuller, Christopher J. Schultz.

10. Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial

Tác giả

Toshihiko Doi, Yukinori Kurokawa, Akira Sawaki, Yoshito Komatsu, Toshirou Nishida.

10. Superior skin cancer classification by the combination of human and artificial intelligence

Tác giả

Achim Hekler, Jochen S. Utikal, Alexander H. Enk, Axel Hauschild, Alexander Thiem.

10. Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data

Tác giả

Wiebke Sondermann, Jochen Sven Utikal, Alexander H. Enk, Dirk Schadendorf, Titus J. Brinker.

10. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme

Tác giả

Romain Varnier, Olivia Le Saux, Sylvie Chabaud, Gwenaëlle Garin, Isabelle Ray-Coquard.

10. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) net

Tác giả

C. Soussain, S. Choquet, M. Blonski, D. Leclercq, K. Hoang-Xuan.

10. Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy

Tác giả

Elmar A. Joura, Maria Kyrgiou, Francisco X. Bosch, Vesna Kesic, Murat Gultekin.

10. Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia

Tác giả

Frédéric Millot, Natacha Maledon, Joelle Guilhot, Adalet Meral Güneş, Meinolf Suttorp.

10. Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives

Tác giả

Teresa de Rojas, Enrico Clementel, Jordi Giralt, Ofelia Cruz, Geert O. Janssens.

10. Combining conventional therapy with immunotherapy: A risky business?

Tác giả

A. Coosemans, A. Vankerckhoven, T. Baert, L. Boon, I. Vergote.

10. Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center

Tác giả

Rebecca A. Harrison, Mark D. Anderson, David Cachia, Carlos Kamiya-Matsuoka, John F. de Groot.

10. Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study

Tác giả

Carole Pflumio, Idriss Troussier, Xu Shan Sun, Julia Salleron, Juliette Thariat.

10. Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry

Tác giả

Francesca Bagnasco, Silvia Caruso, Anita Andreano, Maria Grazia Valsecchi, Simone Cesaro.

10. Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study

Tác giả

Siv Lykke Jørgensen, Ole Mogensen, Chunsen S. Wu, Malene Korsholm, Pernille T. Jensen.

10. The real-world impact of modern treatments on the survival of patients with metastatic melanoma

Tác giả

Marco Donia, Eva Ellebaek, Trine Heide Øllegaard, Lone Duval, Inge Marie Svane.

10. Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

Tác giả

Oliver W. Hakenberg, Jose Luis Perez-Gracia, Daniel Castellano, Tomasz Demkow, Johannes Nippgen.

10. TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)

Tác giả

Tatsuya Ioka, Makoto Ueno, Hideki Ueno, Joon Oh Park, Ichinosuke Hyodo.

11. Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study

Tác giả

Martin D. Forster, Magnus T. Dillon, Judit Kocsis, Éva Remenár, Kevin J. Harrington.

11. Deep and sustained radiological response after MEK-RAF inhibition in HRAS mutant apocrine carcinoma of the scalp

Tác giả

Mariana Scaranti, Daniel Nava Rodrigues, Udai Banerji.

11. Treatment-related mortality in children with cancer: Prevalence and risk factors

Tác giả

Erik A.H. Loeffen, Rutger R.G. Knops, Joren Boerhof, E.A.M. (Lieke) Feijen, Wim J.E. Tissing.

11. Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study

Tác giả

Peter Hohenberger, Sylvie Bonvalot, Frits van Coevorden, Pjotr Rutkowski, Paolo Casali.

11. Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks

Tác giả

Roman C. Maron, Michael Weichenthal, Jochen S. Utikal, Achim Hekler, Alexander Thiem.

11. Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Tác giả

Francesco Perrone, Michelino De Laurentiis, Sabino De Placido, Michele Orditura, Ciro Gallo.

11. Cancer risk in patients with Parkinson’s disease in South Korea: A nationwide, population-based cohort study

Tác giả

Joo-Hyun Park, Do-Hoon Kim, Yong-Gyu Park, Do-Young Kwon, Kyungdo Han.

11. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers

Tác giả

Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, François Planchamp, Isabelle Ray-Coquard.

11. Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017)

Tác giả

Dimitrios Doganis, Anna Zborovskaya, Maciej Trojanowski, Tina Zagar, Eleni Th. Petridou.

11. Recommendations for the organisation of care in paediatric radiation oncology across Europe: a SIOPE–ESTRO–PROS–CCI-Europe collaborative project in the framework of the JARC

Tác giả

Geert O. Janssens, Beate Timmermann, Anne Laprie, Henry Mandeville, Gilles Vassal.

11. The successful treatment of metastatic androgen receptor–positive tumours of parotid origin with androgen receptor blockade and immunotherapy

Tác giả

Angus G. Dalgleish, Silvana Di Palma, Kannon Nathan, Barry Powell, Alberto Fusi.

11. Timing of first-in-child trials of FDA-approved oncology drugs

Tác giả

Dylan V. Neel, David S. Shulman, Steven G. DuBois.

11. Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark

Tác giả

Titus J. Brinker, Achim Hekler, Axel Hauschild, Carola Berking, Jochen S. Utikal.

11. Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: a nationwide study from the Netherlands

Tác giả

Melissa Vos, Harriët G.T. Blaauwgeers, Vincent K.Y. Ho, Winan J. van Houdt, Cornelis Verhoef .

11. The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia

Tác giả

M.M. Frijstein, C.A.R. Lok, D. Short, K. Singh, M.J. Seckl.

11. Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients

Tác giả

Guy Ben-Betzalel, Yael Steinberg-Silman, Ronen Stoff, Nethanel Asher, Gal Markel.

11. Topographical distribution of sentinel nodes and metastases from T1–T2 oral squamous cell carcinomas

Tác giả

Jacob Mølstrøm, Mark Grønne, Anders Green, Vivi Bakholdt, Jens Ahm Sørensen.

11. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis

Tác giả

Tara M. Mackay, Felice N. van Erning, Lydia G.M. van der Geest, Jan Willem B. de Groot, Johanna W. Wilmink.

12. Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma

Tác giả

Ricard Mesia, Paolo Bossi, Aaron R. Hansen, Ching-Yun Hsieh, Robert I. Haddad.

12. Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

Tác giả

Lisa M. Kopp, Suman Malempati, Mark Krailo, Yun Gao, Katherine A. Janeway.

12. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

Tác giả

Robin L. Jones, Mark J. Ratain, Peter J. O'Dwyer, Lillian L. Siu, Gary Schwartz.

12. Clinical and genetic analysis of melanomas arising in acral sites

Tác giả

Anne Zaremba, Rajmohan Murali, Philipp Jansen, Inga Möller, Ioana Cosgarea.

12. Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

Tác giả

L.D. Locati, A. Piovesan, C. Durante, M. Bregni, R. Elisei.

12. Opportunities for improving the efficiency of keratinocyte carcinoma care in primary and specialist care: Results from population-based Dutch cohort studies

Tác giả

M. Wakkee, S. van Egmond, M. Louwman, P. Bindels, L. Hollestein.

12. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)—the final step towards a paradigm shift in surgical staging

Tác giả

Jan Persson, Sahar Salehi, Michele Bollino, Celine Lönnerfors, Barbara Geppert.

12. The European study on centralisation of childhood cancer treatment

Tác giả

G. Gatta, L. Botta, H. Comber, N. Dimitrova, R. Capocaccia.

12. 5-Hydroxytryptamine1a receptors on tumour cells induce immune evasion in lung adenocarcinoma patients with depression via autophagy/pSTAT3

Tác giả

Yi Liu, Hao Zhang, ZhiYong Wang, Pin Wu, Wei Gong.

12. Fluoropyrimidines and DPD testing: is there truly an inexorable link?

Tác giả

Gérard Milano.

12. Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)

Tác giả

Navin Pinto, Arlene Naranjo, Emily Hibbitts, Susan G. Kreissman, Steven G. DuBois.

12. The prognostic value of sentinel lymph nodes on distant metastasis–free survival in patients with high-risk squamous cell carcinoma

Tác giả

Philipp Jansen, Maximilian Petri, Simon F. Merz, Titus J. Brinker, Joachim Klode.

12. Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015

Tác giả

N. Grössmann, M. Robausch, K. Rosian, C. Wild, J. Simon.

12. Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

Tác giả

Neil H. Segal, Sai-Hong I. Ou, Ani Balmanoukian, Matthew G. Fury, Marcus Butler.

12. State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours—a German radiation oncology survey

Tác giả

Lukas Käsmann, Chukwuka Eze, Maurice Dantes, Olarn Roengvoraphoj, Farkhad Manapov.

12. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

Tác giả

Dan P. Zandberg, Alain P. Algazi, Antonio Jimeno, James S. Good, Ricard Mesía.

12. Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

Tác giả

J.W. Holch, I. Ricard, S. Stintzing, L. Fischer von Weikersthal, V. Heinemann.

13. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France

Tác giả

A. Moya-Plana, A. Aupérin, R. Obongo, A. Baglin, M. Wassef.

13. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations

Tác giả

Sally L. George, Elisa Izquierdo, James Campbell, Eleni Koutroumanidou, Louis Chesler.

13. Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia—a report from the UKALL 2011 trial

Tác giả

Rosanna K. Jackson, Martina Liebich, Philip Berry, Julie Errington, Gareth J. Veal.

13. Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management

Tác giả

Helen J. Gogas, Keith T. Flaherty, Reinhard Dummer, Paolo A. Ascierto, Caroline Robert.

13. Impact of cisplatin dose and smoking pack-years in human papillomavirus–positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy

Tác giả

Marc Oliva, Shao Hui Huang, Wei Xu, Jie Su, Anna Spreafico.

13. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup

Tác giả

Rodrigue S. Allodji, Mike M. Hawkins, Chloe J. Bright, Miranda M. Fidler-Benaoudia, Raoul C. Reulen.

13. No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study

Tác giả

Emilia Alfonzo, Emelie Wallin, Linnea Ekdahl, Christian Staf, Pernilla Dahm-Kähler.

13. Breast cancer, placenta and pregnancy

Tác giả

Karolin Froehlich, André Schmidt, Julia Isabell Heger, Boodor Al-Kawlani, Udo Rudolf Markert.

13. Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology

Tác giả

Roberto Salgado, David B. Solit, David L. Rimm, Jan Bogaerts, Vassilis Golfinopoulos.

13. A case of merkel leptomeningeal evolution after complete remission upon anti–PD-1 treatment

Tác giả

Marion Godeau, Cécile Pages-Laurent, Maella Severino-Freire, Elisabeth Guinard, Nicolas Meyer.

13. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials

Tác giả

Sheri L. Spunt, Nadine Francotte, Gian Luca De Salvo, Yueh-Yun Chi, Andrea Ferrari.

13. A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task

Tác giả

Titus J. Brinker, Achim Hekler, Alexander H. Enk, Joachim Klode, Philipp Schrüfer.

13. Prurigo nodularis and pembrolizumab: A therapeutic challenge

Tác giả

Davide Fattore, Luigia Panariello, Maria Carmela Annunziata, Gabriella Fabbrocini.

13. Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

Tác giả

Caroline Robert, Keith Flaherty, Paul Nathan, Peter Hersey, Dirk Schadendorf.

13. Neoepitopes-based vaccines: challenges and perspectives

Tác giả

Vincent Alcazer, Paola Bonaventura, Laurie Tonon, Sandrine Wittmann, Stéphane Depil.

13. An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

Tác giả

James Larkin, Michael P. Brown, Ana M. Arance, Axel Hauschild, Christian Blank.

13. Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments

Tác giả

S. Tavolari, M. Deserti, F. Vasuri, S. Curti, G. Brandi.

14. A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma

Tác giả

Margreet G. Franken, Brenda Leeneman, Maria Gheorghe, Carin A. Uyl-de Groot, Pieter H.M. van Baal.

14. Current state of quality of life and patient-reported outcomes research

Tác giả

Andrew Bottomley, Jaap C. Reijneveld, Michael Koller, Henning Flechtner, Lonneke van de Poll-Franse.

14. Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing

Tác giả

Hong Sook Kim, Hongui Cha, Jinho Kim, Woong-Yang Park, Se-Hoon Lee.

14. Age favoured overall survival in a large population-based Danish patient cohort treated with anti-PD1 immune checkpoint inhibitor for metastatic melanoma

Tác giả

Lars Bastholt, Henrik Schmidt, Jon Kroll Bjerregaard, Jørn Herrstedt, Inge Marie Svane.

14. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

Tác giả

Ketty Peris, Maria Concetta Fargnoli, Claus Garbe, Roland Kaufmann, Jean Jacques Grob.

14. The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review

Tác giả

Luca Mazzarella, Bruno Achutti Duso, Dario Trapani, Carmen Belli, Giuseppe Curigliano.

14. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group

Tác giả

T. Eder, A.K. Hess, R. Konschak, C. Stromberger, I. Tinhofer.

14. Cancer taxonomy: pathology beyond pathology

Tác giả

Manuel Salto-Tellez, Ian A. Cree.

14. Letter to the Editor: Exposure–response or clearance–response relationship in immune checkpoint therapy?—A comment on ‘correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer’ by Basak et al

Tác giả

Mohamed Badawi, Christopher C. Coss, Mitch A. Phelps.

14. Treatment of pembrolizumab-induced cutaneous lesions with ruxolitinib

Tác giả

Chia-Yu Chen, Chang-Fang Chiu, Li-Yuan Bai.

14. Adverse events 2.0—Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology

Tác giả

Lucie Heinzerling, Paolo A. Ascierto, Reinhard Dummer, Helen Gogas, Axel Hauschild.

14. Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients

Tác giả

I.R.N. Verly, R. Leen, J.R. Meinsma, G.K.J. Hooijer, G.A.M. Tytgat.

14. Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab

Tác giả

Martin Dutertre, Mathilde de Menthon, Nicolas Noël, Laurence Albiges, Olivier Lambotte.

14. Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma

Tác giả

B. Shannan, J. Matschke, H. Chauvistré, F. Vogel, A. Roesch.

14. Circulating innate immune markers and outcomes in treatment-naïve advanced non–small cell lung cancer patients

Tác giả

M. Charrier, L. Mezquita, B. Lueza, L. Dupraz, N. Chaput.

14. Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning

Tác giả

Bogdana Suchorska, Ulrich Schüller, Annamaria Biczok, Markus Lenski, Michael Ingrisch.

14. Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

Tác giả

Markus Eckstein, Philipp Erben, Maximilian C. Kriegmair, Thomas S. Worst, Franziska Erlmeier.

15. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden

Tác giả

Imke Satzger, Ulrike Leiter, Nikolai Gräger, Ulrike Keim, Ralf Gutzmer.

15. Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the Netherlands

Tác giả

J.E.W. Walraven, I.M.E. Desar, J.J.M. Hoeven van der, K.K.H. Aben, R.H.A. Verhoeven.

15. Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study

Tác giả

Jair Bar, Gal Markel, Teodor Gottfried, Ruth Percik, Amir Onn.

15. Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)

Tác giả

Paul Nathan, Paolo A. Ascierto, John Haanen, Enrique Espinosa, Dirk Schadendorf.

15. Identification of a functional polymorphism within the 3′-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanoma

Tác giả

Lu Yang, Jie Dai, Meng Ma, Lili Mao, Jun Guo.

15. Olaratumab failure in sarcomas: what are the lessons learned?

Tác giả

Antoine Italiano.

15. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer

Tác giả

Ah Ra Jung, Jong-Lyel Roh, Jae Seung Kim, Sung-Bae Kim, Sang Yoon Kim.

15. Whether vitamin D supplementation protects against colorectal cancer risk remains an open question

Tác giả

P.G. Vaughan-Shaw, L. Zgaga, E. Theodoratou, J.P. Blackmur, M.G. Dunlop.

15. Rechallenge of immune checkpoint inhibitor after pembrolizumab-induced myasthenia gravis

Tác giả

Billal Tedbirt, Michel De Pontville, Pierre Branger, Camille Picard, Julie Delyon.

15. Comment on ‘Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery’

Tác giả

Bin Ma, Qingkai Meng.

15. A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma

Tác giả

Fiona Herd, Nermine O. Basta, Richard J.Q. McNally, Deborah A. Tweddle.

15. A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia

Tác giả

Mathilde Berger, Mona Amini-Adlé, Laura Crumbach, Etienne Paubelle, Stéphane Dalle.

15. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Tác giả

Sigbjørn Smeland, Stefan S. Bielack, Jeremy Whelan, Mark Bernstein, Neyssa Marina.

15. Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery

Tác giả

Gianluca Tomasello, Michele Ghidini, Fausto Petrelli.

15. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core

Tác giả

G. Liegl, M.A. Petersen, M. Groenvold, N.K. Aaronson, S. Nolte.

15. Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer

Tác giả

Makoto Tahara, Marcia S. Brose, Lori J. Wirth, Takuya Suzuki, Andrew Gianoukakis.

16. Health-related quality of life in patients with fully resected BRAFV600 mutation–positive melanoma receiving adjuvant vemurafenib

Tác giả

Dirk Schadendorf, Anna Maria Di Giacomo, Lev Demidov, Barbara Merelli, Karl Lewis.

16. Finnish sauna bathing does not increase or decrease the risk of cancer in men: A prospective cohort study

Tác giả

Jari A. Laukkanen, Timo H. Mäkikallio, Hassan Khan, Tanjaniina Laukkanen, Setor K. Kunutsor.

16. Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study

Tác giả

A. Le Cesne, P. Marec-Berard, J.-Y. Blay, N. Gaspar, A. Italiano.

16. Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images

Tác giả

Achim Hekler, Jochen S. Utikal, Alexander H. Enk, Wiebke Solass, Titus J. Brinker.

16. Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series

Tác giả

Juliette Lemasson, Stefania Cuzzubbo, Ludovic Doucet, Valérie Gounant, Julie Delyon.

16. Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib

Tác giả

Karl Lewis, Axel Hauschild, James Larkin, Antoni Ribas, Paolo A. Ascierto.

16. Development of endocrine immune-related adverse events and improved survival in advanced melanoma patients treated with nivolumab monotherapy

Tác giả

Takuya Maeda, Koji Yoshino, Kojiro Nagai, Satoe Oaku, Hiroo Hata.

16. Melanoma during fingolimod treatment for multiple sclerosis

Tác giả

C. Velter, M. Thomas, A. Cavalcanti, M. Bastien, C. Robert.

16. HPV-circulating tumoural DNA by droplet-based digital polymerase chain reaction, a new molecular tool for early detection of HPV metastatic anal cancer? A case report

Tác giả

David Veyer, Juliette Pavie, Simon Pernot, Marion Mandavit, Hélène Péré.

16. Neurotoxicity induced by targeted therapies in patients treated for metastatic melanoma

Tác giả

C. Velter, C. Libenciuc, E. Routier, C. Mateus, C. Robert.

16. Mitochondrial myopathy associated with anti-programmed cell death 1 therapy

Tác giả

Tony Ibrahim, Clovis Adam, Emilie Routier, Abdelhamid Slama, Caroline Robert.

16. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial

Tác giả

Sandro Pasquali, Sara Pizzamiglio, Nathan Touati, Saskia Litiere, Alessandro Gronchi.

16. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States

Tác giả

S. Nolte, G. Liegl, M.A. Petersen, N.K. Aaronson, M. Rose.

16. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study

Tác giả

S. Stacchiotti, N. Simeone, S. Lo Vullo, C. Morosi, P.G. Casali.

17. Dietary 2-deoxy-D-glucose impairs tumour growth and metastasis by inhibiting angiogenesis

Tác giả

Saurabh Singh, Sanjay Pandey, Amanpreet Singh Chawla, Anant Narayan Bhatt, Bilikere S. Dwarakanath.

17. Metabolic crosstalk in the breast cancer microenvironment

Tác giả

Ana S. Dias, Catarina R. Almeida, Luisa A. Helguero, Iola F. Duarte.

17. Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model

Tác giả

Judith Pape, Tarig Magdeldin, Morium Ali, Claire Walsh, Umber Cheema.

17. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII)

Tác giả

Sarita Depani, Sara Stoneham, Mark Krailo, Caihong Xia, James Nicholson.

17. In response to Ham et al.: Antibiotics effect on outcome in head and neck cancer

Tác giả

Nerina Denaro, Marco Carlo Merlano.

17. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

Tác giả

Alexander M.M. Eggermont, Christian U. Blank, Mario Mandala, Georgina V. Long, Caroline Robert.

17. Comment on ‘Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer’—No support for de-escalation of immunotherapy

Tác giả

Alexandros Georgiou, Anna Minchom, Mary O'Brien.

17. Establishing treatment optimisation as part of personalised medicine development

Tác giả

Denis Lacombe, Gianluca Quaglio, Stéphane Lejeune, Robbe Saesen, Paul Rübig.

17. Letter in response to ‘Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors’

Tác giả

Valérie Leclair, Océane Landon-Cardinal, Marie Hudson.

17. Letter to the editor: Comments on ‘A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica’

Tác giả

David F.L. Liew, Claire E. Owen, Russell R.C. Buchanan.

17. Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast

Tác giả

Davide Fattore, Maria Carmela Annunziata, Luigia Panariello, Claudio Marasca, Gabriella Fabbrocini.

17. Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study

Tác giả

R. Ursu, L. Thomas, D. Psimaras, O. Chinot, A.F. Carpentier.

17. Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials

Tác giả

Y. Kanjanapan, D. Day, M.O. Butler, L. Wang, A. Spreafico.

17. All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Tác giả

Meletios A. Dimopoulos, Sebastian Grosicki, Wiesław W. Jędrzejczak, Hareth Nahi, Shaji Kumar.

18. Revocation of the conditional marketing authorisation of a cancer medicine: The olaratumab experience

Tác giả

Ralf Herold, Jorge Camarero, Daniela Melchiorri, Zigmars Sebris, Francesco Pignatti.

18. Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets

Tác giả

A. Moreira, J. Masliah-Planchon, C. Callens, S. Vacher, M. Kamal.

18. Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy

Tác giả

Ahmed Mekki, Laurent Dercle, Philip Lichtenstein, Ghaida Nasser, Samy Ammari.

18. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study

Tác giả

Najat C. Daw, Yueh-Yun Chi, Yeonil Kim, Elizabeth A. Mullen, Jeffrey S. Dome.

18. More rationale for optimal sequencing of therapeutic monoclonal antibodies in metastatic colorectal cancer

Tác giả

Gerard Milano.

18. Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

Tác giả

Sophia Kreft, Anja Gesierich, Thomas Eigentler, Cindy Franklin, Bastian Schilling.

18. Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy

Tác giả

Collin K. Chin, Sara Hall, Celia Green, Guy Van Hazel, Chan Yoon Cheah.

18. Vision loss after chemotherapy: an irinotecan-induced retinopathy

Tác giả

Alice Boilève, Mathieu Jozwiak, David Malka, Valérie Boige, Michel Ducreux.

18. Volume effect in paediatric brain tumour resection surgery: analysis of data from the Japanese national inpatient database

Tác giả

Daisuke Shinjo, Kimikazu Matsumoto, Keita Terashima, Tetsuya Takimoto, Kiyohide Fushimi.

18. Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Tác giả

Omar Hasan Ali, Fiamma Berner, David Bomze, Mirjam Fässler, Lukas Flatz.

18. Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT

Tác giả

Sebastian Giebel, Myriam Labopin, Tomasz Czerw, Gérard Socié, Arnon Nagler.

19. Negative phase III trials announce the need for biomarkers in sarcoma

Tác giả

Alexander TJ. Lee, Paul H. Huang, Robin L. Jones.

19. Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting

Tác giả

Pauline Corbaux, Denis Maillet, Amélie Boespflug, Myriam Locatelli-Sanchez, Julien Péron.

19. Breastfeeding during R-CHOP chemotherapy: please abstain!

Tác giả

Giovanni Codacci-Pisanelli, Richard J. Honeywell, Natalie Asselin, Giulia Bellettini, Fedro A. Peccatori.

19. Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989–2015

Tác giả

O.L. van der Hel, M. Timmermans, A.M. van Altena, R.F.P.M. Kruitwagen, M.A. van der Aa.

19. The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

Tác giả

Marijke Coomans, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin J.B. Taphoorn.

19. Three cases of immune cholangitis related to anti–programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer

Tác giả

Maxime Fouchard, Helene Jantzem, Gilles Quere, Renaud Descourt, Pierre-Guillaume Poureau.

19. A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia

Tác giả

Mathilde Berger, Mona Amini-Adlé, Laura Crumbach, Etienne Paubelle, Stéphane Dalle.

19. Symptom documentation and intervention provision for symptom control in children receiving cancer treatments

Tác giả

Shannon Hyslop, Hailey Davis, Nathan Duong, Robyn Loves, Lillian Sung.

19. A novel risk calculator to predict outcome after surgery for symptomatic spinal metastases; use of a large prospective patient database to personalise surgical management

Tác giả

David Choi, Menelaos Pavlou, Rumana Omar, Mark Arts, Hugh Alan Crockard.

19. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report

Tác giả

Daniel C. Aronson, Víola B. Weeda, Rudolf Maibach, Piotr Czauderna, Laurence Brugières.

20. Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors

Tác giả

Aurore Vozy, Eleonora De Martin, Douglas B. Johnson, Bénédicte Lebrun-Vignes, Joe-Elie Salem.

20. Immune gene expression in head and neck squamous cell carcinoma patients

Tác giả

Charlotte Lecerf, Maud Kamal, Sophie Vacher, Walid Chemlali, Christophe Le Tourneau.

20. The use of buparlisib as a radiosentisiser: What about toxicity?

Tác giả

Peter A. van Dam.

20. Future reduction of cutaneous malignant melanoma due to improved sun protection habits and decreased common melanocytic nevi density among Swedish children?: A follow-up from 2002 to 2012

Tác giả

Ylva Rodvall, Carl-Fredrik Wahlgren, Kerstin Wiklund.

20. Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial

Tác giả

Sabine Irtan, Harm Van Tinteren, Norbert Graf, Marry M. van den Heuvel-Eibrink, Kathy Pritchard-Jones.

20. Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

Tác giả

J. Rogado, J.M. Sánchez-Torres, N. Romero-Laorden, A.I. Ballesteros, R. Colomer.

20. A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy

Tác giả

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man, Didier Meulendijks, Jan H.M. Schellens.

20. Long-term health and social function in adult survivors of paediatric astrocytoma: A report from the Childhood Cancer Survivor Study

Tác giả

Karen E. Effinger, Kayla L. Stratton, Paul Graham Fisher, Kirsten K. Ness, Paul C. Nathan.

21. Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data’ [Eur J Cancer, 119 (September 2019) Pages 30–34]

Tác giả

Wiebke Sondermann, Jochen Sven Utikal, Alexander H. Enk, Dirk Schadendorf, Titus J. Brinker.

21. Comparison of treatment effect from randomised controlled phase II trials and subsequent phase III trials using identical regimens in the same treatment setting

Tác giả

Fei Liang, Zhenyu Wu, Miao Mo, Changming Zhou, Ying Zheng.

21. Reply to ‘The use of buparlisib as a radiosensitiser: What about toxicity?’

Tác giả

Daniel R. McGowan, Michael Skwarski, Geoff S. Higgins.

21. Acute pancreatitis after vismodegib for basal cell carcinoma: a causal relation?

Tác giả

C. Velter, J. Blanc, C. Robert.

21. Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer—a follow-up study

Tác giả

Marianne Ørum, Kenneth Jensen, Merete Gregersen, Peter Meldgaard, Else Marie Damsgaard.

21. Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth

Tác giả

Kaitlyn Johnson, Axel Gomez, Jackson Burton, Douglas White, Dean Bottino.

21. Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab

Tác giả

Shoko Noda-Narita, Suguru Mizuno, Satoshi Noguchi, Kousuke Watanabe, Takahide Nagase.

21. Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti–programmed death-1 and anti–programmed death ligand 1 trials

Tác giả

Run-Cong Nie, Fo-Ping Chen, Shu-Qiang Yuan, Ying-Shan Luo, Zhi-Wei Zhou.

22. Cerebrospinal fluid lymphocytosis: a hallmark of neurological complications during checkpoint inhibition

Tác giả

Erwin H.J. Tonk, Tom J. Snijders, José J. Koldenhof, Anne S.R. van Lindert, Karijn P.M. Suijkerbuijk.

22. Corrigendum to ‘A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours’ [Eur J Cancer 104 (November 2018) 1–8]

Tác giả

Anas Gazzah, Valentina Boni, Jean-Charles Soria, Antonio Calles, Emiliano Calvo.

22. Assessing the risk of bias and publication bias should be integral parts of the systematic review

Tác giả

Jianjian Chen, Yahua Li, Xueliang Zhou, Zhaonan Li, Xinwei Han.

22. Probability of sentinel lymph node positivity in melanoma

Tác giả

Mary-Ann El Sharouni, Arjen J. Witkamp, Vigfús Sigurdsson, Paul J. van Diest.

22. CMV disease and colitis in a kidney transplanted patient under pembrolizumab

Tác giả

Juliette Gueguen, Elodie Bailly, Laurent Machet, Elodie Miquelestorena-Standley, Matthias Büchler.

22. Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide

Tác giả

Adan Rios, Putao Cen, Brian Dinh, Steven R. Mays, Anisha B. Patel.

22. Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

Tác giả

Alvaro Moreira, Carmen Loquai, Claudia Pföhler, Katharina C. Kähler, Lucie Heinzerling.

23. Eltrombopag treatment for severe refractory thrombocytopenia caused by pembrolizumab

Tác giả

Peng Song, Li Zhang.

23. Corrigendum to “Parasites and immunotherapy: Immunostimulatory effect of Leishmania spp. in cancer treatment” [Eur J Cancer 110 (1) (March 2019) S33]

Tác giả

A. Caner, M. Erdogan, D. Namlıses, A. Sadıqova, A. Haydaroglu.

23. Response to: Assessing the risk of bias and publication bias should be integral parts of the systematic review

Tác giả

Mairéad Geraldine McNamara, Eitan Amir.

23. Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patients

Tác giả

Taketo Kawai, Yusuke Sato, Katsuhiro Makino, Yuta Yamada, Haruki Kume.

23. Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors

Tác giả

Alice de Malet, Guillemette Antoni, Michael Collins, Emilie Soularue, Franck Carbonnel.

24. Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia

Tác giả

Min Chul Choi, Jisu Oh, Chan Lee.

24. Erratum to ‘Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma’ [Eur J Cancer 108 (February 2019) 33–40]

Tác giả

Marie Auvray, Edouard Auclin, Philippe Barthelemy, Petri Bono, Laurence Albiges.

24. Erratum to ‘Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)’ [Eur J Cancer 107 (January 2019) 46–52]

Tác giả

S. Watson, C. de la Fouchardière, S. Kim, R. Cohen, C. Louvet.

24. Generalised morphea induced by pembrolizumab

Tác giả

Hugo Herrscher, Gorana Tomasic, Alicia Castro Gordon.

24. A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology

Tác giả

Alyson Haslam, Spencer P. Hey, Jennifer Gill, Vinay Prasad.

25. BRAF exon 11 mutant melanoma and sensitivity to BRAF/MEK inhibition: Two case reports

Tác giả

Audrey Melin, Emilie Routier, Hubert Tissot, Etienne Rouleau, Caroline Robert.

25. Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti–programmed death 1 antibody

Tác giả

T. Shirai, Y. Kiniwa, R. Sato, T. Sano, R. Okuyama.

26. Nivolumab-related mucous membrane pemphigoid

Tác giả

Vincent Sibaud, Emmanuelle Vigarios, Aurore Siegfried, Chloe Bost, Cecile Pages-Laurent.

26. Diet-dependent toxicity of ipilimumab in metastatic melanoma

Tác giả

P. Majenka, M. Hoffmann, I. Rötzer, A. Dimitrakopoulou-Strauss, J.C. Hassel.

27. Reviewers 2018

Tác giả